Myasthenia gravis exacerbation after melatonin administration: case series from a tertiary referral centre

Myasthenia gravis exacerbation after melatonin administration: case series from a tertiary referral centre

Abstract Background Myasthenia gravis is an autoimmune disease mediated by antibodies against proteins associated with the postsynaptic membrane of the neuromuscular junction. Several drugs may trigger an exacerbation of the disease. Melatonin supplements are widely used for the treatment of insomni...

Full description

Bibliographic Details
Main Authors: Velina Nedkova-Hristova, Valentina Vélez-Santamaría, Carlos Casasnovas
Format: Article
Language:English
Published: BMC 2020-11-01
Series:BMC Neurology
Subjects:
Melatonin
Myasthenia gravis
Corticosteroid
Immunosuppressant
Case report
Online Access:http://link.springer.com/article/10.1186/s12883-020-01975-y

Internet

http://link.springer.com/article/10.1186/s12883-020-01975-y

Similar Items